Behavioural disinhibition in frontotemporal dementia investigated within an ecological framework.

Behaviour Compulsivity Ecological setting Impulsivity Non-pharmacological management Social disinhibition

Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
03 2023
Historique:
received: 02 02 2022
revised: 29 09 2022
accepted: 09 11 2022
pubmed: 20 1 2023
medline: 15 3 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

Disinhibition is a core symptom in behavioural variant frontotemporal dementia (bvFTD) particularly affecting the daily lives of both patients and caregivers. Yet, characterisation of inhibition disorders is still unclear and management options of these disorders are limited. Questionnaires currently used to investigate behavioural disinhibition do not differentiate between several subtypes of disinhibition, encompass observation biases and lack of ecological validity. In the present work, we explored disinhibition in an original semi-ecological situation, by distinguishing three categories of disinhibition: compulsivity, impulsivity and social disinhibition. First, we measured prevalence and frequency of these disorders in 23 bvFTD patients and 24 healthy controls (HC) in order to identify the phenotypical heterogeneity of disinhibition. Then, we examined the relationships between these metrics, the neuropsychological scores and the behavioural states to propose a more comprehensive view of these neuropsychiatric manifestations. Finally, we studied the context of occurrence of these disorders by investigating environmental factors potentially promoting or reducing them. As expected, we found that patients were more compulsive, impulsive and socially disinhibited than HC. We found that 48% of patients presented compulsivity (e.g., repetitive actions), 48% impulsivity (e.g., oral production) and 100% of the patients group showed social disinhibition (e.g., disregards for rules or investigator). Compulsivity was negatively related with emotions recognition. BvFTD patients were less active if not encouraged in an activity, and their social disinhibition decreased as activity increased. Finally, impulsivity and social disinhibition decreased when patients were asked to focus on a task. Summarising, this study underlines the importance to differentiate subtypes of disinhibition as well as the setting in which they are exhibited, and points to stimulating area for non-pharmacological management.

Identifiants

pubmed: 36658040
pii: S0010-9452(22)00333-1
doi: 10.1016/j.cortex.2022.11.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-166

Investigateurs

Bénédicte Batrancourt (B)
Carole Azuar (C)
Bruno Dubois (B)
Karen Lecouturier (K)
Carla M Araujo (CM)
Estelle Janvier (E)
Aline Jourdain (A)
Armelle Rametti-Lacroux (A)
Sophie Coriou (S)
Vanessa B Brochard (VB)
Cécile Gaudebout (C)
Johan Ferrand-Verdejo (J)
Louis Bonnefous (L)
Flore Pochan-Leva (F)
Lucie Jeanne (L)
Mathilde Joulié (M)
Myriam Provost (M)
Rozenn Renaud (R)
Sarah Hachemi (S)
Vincent Guillemot (V)
David Bendetowicz (D)
Guilhem Carle (G)
Julie Socha (J)
Fanny Pineau (F)
Frédéric Marin (F)
Yongjian Liu (Y)
Pierre Mullot (P)
Aymen Mousli (A)
Armelle Blossier (A)
Giulia Visentin (G)
Delphine Tanguy (D)
Valérie Godefroy (V)
Idil Sezer (I)
Mathilde Boucly (M)
Blandine Cabrol-Douat (B)
Raphaëlle Odobez (R)
Constance Marque (C)
Daphné Tessereau-Barbot (D)
Anaïs Raud (A)
Aurélie Funkiewiez (A)
Céline Chamayou (C)
Emmanuel Cognat (E)
Manon Le Bozec (M)
Arabella Bouzigues (A)
Vincent Le Du (V)
Stéphanie Bombois (S)
Camille Simard (C)
Paolo Fulcheri (P)
Hortense Guitton (H)
Caroline Peltier (C)
François-Xavier Lejeune (FX)
Lars Jorgensen (L)
Louise-Laure Mariani (LL)
Jean-Christophe Corvol (JC)
Antoni Valero-Cabre (A)
Béatrice Garcin (B)
Emmanuelle Volle (E)
Isabelle Le Ber (I)
Raffaella Migliaccio (R)
Richard Levy (R)

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no competing interests.

Auteurs

Delphine Tanguy (D)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France; Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France.

Armelle Rametti-Lacroux (A)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.

Arabella Bouzigues (A)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.

Dario Saracino (D)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtriѐre, Department of Neurology, IM2A, Paris, France.

Isabelle Le Ber (I)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtriѐre, Department of Neurology, IM2A, Paris, France.

Valérie Godefroy (V)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.

Xavier Morandi (X)

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France.

Pierre Jannin (P)

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France.

Richard Levy (R)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France; Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France; AP-HP, Groupe Hospitalier Pitié-Salpêtriѐre, Department of Neurology, IM2A, Paris, France.

Bénédicte Batrancourt (B)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France. Electronic address: benedicte.batrancourt@upmc.fr.

Raffaella Migliaccio (R)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, FrontLab, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtriѐre, Department of Neurology, IM2A, Paris, France. Electronic address: lara.migliaccio@icm-institute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH